Dyslexia treatment is used to help individuals with dyslexia learn fundamental reading and writing skills and build overall literacy abilities. Dyslexia treatment involves targeted therapy and education tailored to the specific needs of each individual. It aims to improve phonological processing, orthographic skills, reading fluency, spelling and writing skills.
Global dyslexia treatment market is estimated to be valued at USD 7.59 Bn in 2024 and is expected to reach USD 11.74 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.
Key Takeaways
Key players: Key players operating in the dyslexia treatment market include copyright, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Jubilant Pharma Limited, GSK plc, Eli Lilly and Company, Otsuka Holdings Co., Ltd., Apotex Corporation, Purdue Pharma, Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd., Wallace Pharmaceuticals Ltd., The Himmel Group, Astrazeneca, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Lupin.
Key opportunities: Rising awareness about Dyslexia Treatment Market Demand and government support for early screening and diagnosis presents key opportunities for players in the dyslexia treatment market. Additionally, increasing adoption of e-learning and digital programs for dyslexia therapy will augment future growth prospects.
Global expansion: Major players are focused on expanding their geographical footprint in high growth emerging markets of Asia Pacific and Latin America. Partnerships with local players and launches of low-cost treatment offerings are facilitating global expansion strategies.
Market drivers: The growing global burden of dyslexia owing to rising academic pressure and extensive use of digital devices is a major market driver. Furthermore, the launch of novel treatment drugs and the approval of first drug therapy for dyslexia by the FDA in recent years will further augment demand over the forecast period.
PEST Analysis
Political: Regulations for healthcare and treatment are becoming more stringent. Governments are also providing more funding for treatment and awareness programs.
Economic: With rising disposable incomes, more people are able to afford dyslexia treatment. However, economic slowdowns may result in budget cuts for public healthcare.
Social: Acceptance towards neurological conditions is increasing. People are more open in seeking help. Social stigma around learning disabilities is reducing.
Technological: Apps and software are being developed to make learning easier for those with dyslexia. Audio books and text-to-speech technologies are widely used. Virtual reality tools are being researched to improve cognitive skills.
North America accounts for the largest share of the dyslexia treatment market in terms of value. This is due to the developed healthcare infrastructure and high healthcare spending in countries like the US and copyright.
The Asia Pacific region is expected to be the fastest growing market during the forecast period. Factors such as rising disposable incomes, growing awareness, and increasing research funding are contributing to the growth. Countries like China and India offer huge potential due to their large population sizes. Growing medical tourism is also boosting the Asia Pacific dyslexia treatment market.
Get more insights on Dyslexia Treatment Market
Also read related article on Dental Implants Market
Get More Insights—Access the Report in the Language that Resonates with You
French
German
Italian
Russian
Japanese
Chinese
Korean
Portuguese
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)